Mercato europeo della narcolessia fino al 2027 – Analisi regionale e previsioni per tipologia (narcolessia con cataplessia, narcolessia senza cataplessia e narcolessia secondaria); Prodotto (stimolanti del sistema nervoso centrale (SNC), sodio oxibato e antidepressivi); Canale distributivo (Farmacie ospedaliere e Farmacie al dettaglio) e Paese

Historic Data: 2016-2017   |   Base Year: 2018   |   Forecast Period: 2019-2027


No. of Pages: 123    |    Report Code: TIPRE00008098    |    Category: Life Sciences

Europe Narcolepsy Market

Si prevede che il mercato europeo della narcolessia raggiungerà 1.532,5 milioni di dollari nel 2027 rispetto a 671,1 milioni di dollari nel 2018. Si prevede che il mercato della narcolessia aumenterà con un CAGR del 9,7% nel periodo 2019-2027. .

 

Si stima che il mercato della narcolessia crescerà a causa dei fattori chiave fattori trainanti come la crescente ricerca e sviluppo e la crescente consapevolezza in tutta la regione. Tuttavia, è probabile che fattori come le sfide legate alla narcolessia agiscano come un importante fattore frenante per la crescita del mercato.

 

< p>La narcolessia è un raro disturbo cronico del sonno causato dalla perdita dei neuroni che producono ipocretina. Sono stati fatti vari sviluppi per produrre medicinali in grado di ridurre i sintomi della narcolessia. Numerose ricerche e sviluppi vengono condotti in paesi come Germania, Regno Unito e altri paesi della regione europea. Ad esempio, nell\'aprile 2019, in Germania, sono state svolte attività di ricerca e sviluppo presso l\'Inserm e l\'Université di Montpellier. La ricerca è stata condotta in collaborazione con team internazionali che hanno contribuito a condurre studi epidemiologici e clinici per il farmaco Solriamfetol tra le persone che vivono con la narcolessia.

 

Inoltre, lo studio è stato condotto in collaborazione con Jazz Pharmaceuticals, la società ha investito nella sperimentazione e detiene anche una licenza per sviluppare e commercializzare Solriamfetol. Lo studio era una sperimentazione clinica di fase III e i risultati hanno mostrato che il farmaco non ha effetti collaterali per i pazienti che convivono con la narcolessia. Pertanto, a causa delle crescenti attività di ricerca e sviluppo per la narcolessia, è probabile che aumenti la crescita del mercato durante il periodo di previsione.

 

Entrate e previsioni del mercato della narcolessia in Germania fino al 2027 (milioni di dollari)


< /span>

 

 

Narcolessia europea: – Segmentazione del mercato

 

Mercato europeo della narcolessia: – Per tipo

  • Narcolessia con cataplessia
  • Narcolessia senza cataplessia
  • Narcolessia secondaria

 

Mercato europeo - Per prodotto

  • Stimolanti del sistema nervoso centrale (SNC)
  • Oxibato di sodio
  • Antidepressivi

 

Mercato europeo - Per canale di distribuzione

  • Farmacie ospedaliere
  • Farmacie al dettaglio

 

Per area geografica

  • Europa

    • Stati Uniti
    • Canada
    • Messico

 

Profili aziendali

  • Teva Pharmaceutical Industries Ltd.
  • Jazz Pharmaceuticals plc< /span>
  • Arena Pharmaceuticals, Inc.
  • Graymark Healthcare, Inc.
  • Novartis AG
  • Takeda Pharmaceutical Company Limited
  • Mylan NV
  • BIOPROJET
  • Shionogi & Co., Ltd.
  • Ligand Pharmaceuticals, Inc


Europe Narcolepsy Strategic Insights

Strategic insights for Europe Narcolepsy involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/europe-narcolepsy-market-strategic-framework.webp
Get more information on this report

Europe Narcolepsy Report Scope

Report Attribute Details
Market size in 2018 US$ 671.1 Million
Market Size by 2027 US$ 1,532.5 Million
Global CAGR (2019 - 2027) 9.7%
Historical Data 2016-2017
Forecast period 2019-2027
Segments Covered By Tipo
  • Narcolessia con cataplessia
  • Narcolessia senza cataplessia
  • Narcolessia secondaria
By Prodotto
  • Stimolanti del sistema nervoso centrale
  • sodio oxibato
  • antidepressivi
By Canale di distribuzione
  • farmacie ospedaliere
  • farmacie al dettaglio
Regions and Countries Covered Europa
  • Regno Unito
  • Germania
  • Francia
  • Russia
  • Italia
  • resto Europa
Market leaders and key company profiles
  • Teva Pharmaceutical Industries Ltd.
  • Jazz Pharmaceuticals plc
  • Arena Pharmaceuticals, Inc.
  • Graymark Healthcare, Inc.
  • Novartis AG
  • Takeda Pharmaceutical Company Limited
  • Mylan N.V.
  • BIOPROJET
  • Shionogi & Co., Ltd.
  • Ligand Pharmaceuticals, Inc
  • Get more information on this report

    Europe Narcolepsy Regional Insights

    The regional scope of Europe Narcolepsy refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/europe-narcolepsy-market-geography.webp
    Get more information on this report

    The List of Companies - Europe Narcolepsy Market

    The List of Companies - Europe Narcolepsy Market

    1. Teva Pharmaceutical Industries Ltd.
    2. Jazz Pharmaceuticals plc
    3. Arena Pharmaceuticals, Inc.
    4. Graymark Healthcare, Inc.
    5. Novartis AG
    6. Takeda Pharmaceutical Company Limited
    7. Mylan N.V.
    8. BIOPROJET
    9. Shionogi & Co., Ltd.
    10. Ligand Pharmaceuticals, Inc

     

    Frequently Asked Questions
    How big is the Europe Narcolepsy Market?

    The Europe Narcolepsy Market is valued at US$ 671.1 Million in 2018, it is projected to reach US$ 1,532.5 Million by 2027.

    What is the CAGR for Europe Narcolepsy Market by (2019 - 2027)?

    As per our report Europe Narcolepsy Market, the market size is valued at US$ 671.1 Million in 2018, projecting it to reach US$ 1,532.5 Million by 2027. This translates to a CAGR of approximately 9.7% during the forecast period.

    What segments are covered in this report?

    The Europe Narcolepsy Market report typically cover these key segments-

  • Tipo (Narcolessia con cataplessia, Narcolessia senza cataplessia, Narcolessia secondaria)
  • Prodotto (Stimolanti del sistema nervoso centrale, sodio oxibato, antidepressivi)
  • Canale di distribuzione (farmacie ospedaliere, farmacie al dettaglio)
  • What is the historic period, base year, and forecast period taken for Europe Narcolepsy Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Narcolepsy Market report:

  • Historic Period : 2016-2017
  • Base Year : 2018
  • Forecast Period : 2019-2027
  • Who are the major players in Europe Narcolepsy Market?

    The Europe Narcolepsy Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Teva Pharmaceutical Industries Ltd.
  • Jazz Pharmaceuticals plc
  • Arena Pharmaceuticals, Inc.
  • Graymark Healthcare, Inc.
  • Novartis AG
  • Takeda Pharmaceutical Company Limited
  • Mylan N.V.
  • BIOPROJET
  • Shionogi & Co., Ltd.
  • Ligand Pharmaceuticals, Inc
  • Who should buy this report?

    The Europe Narcolepsy Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Europe Narcolepsy Market value chain can benefit from the information contained in a comprehensive market report.